A unique model
IRIC, located in the heart of the Université de Montréal campus, operates according to a unique model in Canada that combines, under one roof, fundamental research activities, a university-level training program and a research maturation team. These generate discoveries that advance knowledge or that can quickly translate into new therapeutic solutions.
-
News The winners of the 2026 IRIC Next Generation Competition are joining the Institute!
This summer, 12 students have the opportunity to complete a 12- or 16-week research internship at IRIC, in addition to receiving an excellence scholarship.
-
News Michel Bouvier Named Officer of the Order of Canada
Professor Michel Bouvier, director of IRIC’s Molecular Pharmacobiology Research Unit, has been named an Officer of the Order of Canada by the Governor General.
-
News 2026 Student Recruitment Event: Meet the scientific talents of tomorrow!
Each year, the IRIC Student Recruitment Event offers students interested in pursuing graduate studies in cancer research a unique opportunity to participate in an international recruitment event at the Institute for Research in Immunology and Cancer at the University of Montreal.
-
News More than $1 million in grant for Michel Bouvier and the startup Drave Therapeutics
The team of Michel Bouvier, director of IRIC’s Molecular Pharmacology Research Unit, receives $1,08 M for a project in precision pharmacology of G protein-coupled receptors (GPCR). This grant is supported by the Consortium québécois sur la découverte du médicament (CQDM), through the Ministère de l’Économie, de l’Innovation et de l’Énergie du Québec, and by the co-funding partners Drave Therapeutics and the Université de Montréal.
-
News Claude Perreault Named Knight of the Ordre national du Québec
On June 17, Professor Claude Perreault, director of IRIC’s Immunobiology Research Unit, will be awarded the title of Knight of the Ordre national du Québec.
-
News A “super-skeleton” that transmits mechanical forces to the cell surface
The team led by Gregory Emery, director of IRIC’s Vesicular Trafficking and Cell Signalling Research Unit, has identified a dynamic structure that forms a network on the surface of epithelial cells. The work, led by PhD students Claire Baudouin and Léa Marpeaux, is the subject of a publication in the Journal of Cell Science. The article made the journal’s cover and is accompanied by an interview with the two students.
Latest publications
See all publications-
June 18, 2026 Apelin analog treatment reverses severe pulmonary arterial hypertension and right ventricular heart failure.
Vu J, Zhabyeyev P, Brown KJ, Gorham JM, DeLaughter DM, Chen H, Jayawardena TU, Vergara A, Alexiou M, Wijewardane A, Fischer C, Avet C, Ewasiuk A, Wang F, Chappell MC, Kim Y, Bouvier M, Vederas JC, Seidman CE, Seidman JG, Oudit GY
JCI Insight 2026-06-18 ; -
June 18, 2026 Immunosuppressive myeloid cells induce mesenchymal-like breast cancer stem cells by a membrane-bound TGF-β1-dependent mechanism.
Boyer T, Blaye C, Chalopin D, Madéry M, Boucher J, Moisand A, Theodoly-Lannes A, Giraud J, Peyraud F, Seeneevassen L, Klein C, Mebroukine S, Auriol S, Chaibi A, Zouine A, Izotte J, Charrot LM, Alizadeh D, Iggo R, MacGrogan G, Lamarthée B, Bonnotte B, Bonneil E, Roux PP, Varon C, Domblides C, Larmonier N
Cell Rep 2026-06-18 ;45( 7 ):117568 -
June 11, 2026 STING dampens the unfolded protein response to enable the presentation of self-antigens on MHC-I during inflammation.
Fahmy AM, Ahmadi A, Lanoix J, Cannon T, Elemeery MN, Paredes CH, Barrette B, Bonneil E, Xu YZ, Ibrahim M, Arango-Duque G, Audemard EO, Lemieux S, Chevet E, Schurr E, Pierre P, Gruenheid S, Thibault P, McBride HM, Desjardins M
Cell Rep 2026-06-11 ;45( 6 ):117497 - See all publications